Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Peretz

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Anti-Cancer Drugs|March 10, 1998
Cisplatin-induced non-convulsive encephalopathyO Lyass, A Lossos, A Hubert, et al.
Harefuah|January 15, 1986
[New frontiers in cancer chemotherapy: cis-platinum]A Sulkes, T Peretz, S Rizel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGyL Mandell, F Ghavimi, T Peretz, et al.
Harefuah|January 15, 1984
[Home epidural morphine analgesia]B Klin, T Peretz, R Catan, et al.
Clinical Nuclear Medicine|January 4, 2001
The use of external radioactive markers in scintimammographyM Klein, J Weininger, S Moshe, et al.
Oncogene|February 14, 2006
Tumor suppressor p53 regulates heparanase gene expressionL Baraz, Y Haupt, M Elkin, et al.
Journal of Molecular Neuroscience : MN|January 1, 1996
Deletion of the N-terminus of a K+ channel brings about short-term modulation by cAMP and beta 1-adrenergic receptor activationG Levin, T Peretz, D Chikvashvilli, et al.
Gynecologic Oncology|March 1, 1994
Ovarian stimulation and breast cancer: is there a link?A Brzezinski, T Peretz, S Mor-Yosef, et al.
Journal of Cellular Physiology|September 1, 1995
Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activityH Q Miao, R Ishai-Michaeli, T Peretz, et al.
JAMA|March 26, 1997
BRCA1 mutations in women with ovarian cancerA Shushan, D Abeliovich, T Peretz, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Anti-Cancer Drugs|March 10, 1998
Cisplatin-induced non-convulsive encephalopathyO Lyass, A Lossos, A Hubert, et al.
Harefuah|January 15, 1986
[New frontiers in cancer chemotherapy: cis-platinum]A Sulkes, T Peretz, S Rizel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGyL Mandell, F Ghavimi, T Peretz, et al.
Harefuah|January 15, 1984
[Home epidural morphine analgesia]B Klin, T Peretz, R Catan, et al.
Clinical Nuclear Medicine|January 4, 2001
The use of external radioactive markers in scintimammographyM Klein, J Weininger, S Moshe, et al.
Oncogene|February 14, 2006
Tumor suppressor p53 regulates heparanase gene expressionL Baraz, Y Haupt, M Elkin, et al.
Journal of Molecular Neuroscience : MN|January 1, 1996
Deletion of the N-terminus of a K+ channel brings about short-term modulation by cAMP and beta 1-adrenergic receptor activationG Levin, T Peretz, D Chikvashvilli, et al.
Gynecologic Oncology|March 1, 1994
Ovarian stimulation and breast cancer: is there a link?A Brzezinski, T Peretz, S Mor-Yosef, et al.
Journal of Cellular Physiology|September 1, 1995
Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activityH Q Miao, R Ishai-Michaeli, T Peretz, et al.
JAMA|March 26, 1997
BRCA1 mutations in women with ovarian cancerA Shushan, D Abeliovich, T Peretz, et al.
Pageof 11